Preview

International Marketing Plan for Blackmore's Cold and Flu

Powerful Essays
Open Document
Open Document
4700 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
International Marketing Plan for Blackmore's Cold and Flu
International marketing plan
Blackmores Cold and Flu

Table of contents

Executive Summary 3
Product description 4
Market Description 6
Market 6
OTC Medicine features 7
Main self-medication product groups 7
OTC categories in India 8
Comparison with competitors’ product 8
Direct and indirect competitors 8
Factors that make Blackmores stand out from its competitors? 9
Target market size 10
Government Participation 11
Marketing processes 12
Marketing objectives via new strategy of implementation 12
Product adaptation 15
Promotional mix 15
Advertising to the general public 15
Promotion via health care providers 16
Distribution from origin to destination 17
Channel management 17
Distribution processes 18
Price determination 19
Conclusion 21
References 22

Executive Summary

Choosing India as a destination to market Blackmores’ Cold/Flu Night & Day may seem radical; however the company has strong belief that this will benefit them not only in the short run, but in the long run too. India is reported to have one of the fasted growing pharmaceutical industries in the world with advanced technologies and many other contributing factors, which can be adopted by Blackmores to become a market leader in their industry.
Currently the industry is highly regulated; however trends seem to be changing. Factors contributing to this change are the sheer size and growth of Indian domestic pharmaceutical industry, which as a result makes it increasingly difficult for the government to regulate every firms. Secondly pressure being applied from World trade Organisation to speed up discussions within the national government to improve patent protection. This will result in providing foreign pharmaceutical firms being provided improved marketing opportunities in the Indian Enormous Drug market over years to come. Blackmores however would like to get a head start and move in to get a strong foothold in this industry by marketing the Cold/Flu Night And Day



References: Belch, G. & Belch, M. (2001) Advertising and Promotion, McGraw Hill, Australia Bhangale, V.(2007) Cateora, P. & Graham, J. (2009) International Marketing, McGraw Hill, Australia Czinkota, M Dumont, J-C. & Lemaitre, G. (2009) Counting Immigrants and expatriates in OECD COUNTRIES: A new perspective. Retrieved October 16, 2001, from http://www.oecd.org/dataoecd/27/5/33868740.pdf. Fletcher, R., Brown, L. (2008), International Marketing - An Asia Pacific Perspective, 4TH Edition, Prentice Hall, Australia Keegan, W Kotler, P. & Armstrong, G. (2006), Principles of marketing, 11th edition, Pearson Prentice Hall. Media Contact Resources Neoncarrot (2009). Indian Tourism Statistics. Retrieved October 16, 2001, from http://www.neoncarrot.co.uk/h_aboutindia/india_tourism_stats.html#touris . Pharmaceutical and drug manufacturers (2010). Pharma Industry Statistics. Retrieved October 16, 2001, from http://www.pharmaceutical-drug-manufacturers.com/pharma-industry-statistics/. William, G. (2007). The Emergence of India’s Pharmaceutical Industry and Implications for the US Generic

You May Also Find These Documents Helpful

  • Best Essays

    Pfizer Competitor Analysis

    • 3793 Words
    • 16 Pages

    The value that the branded pharmaceutical industry adds to the US economy is growing slower than US GDP (Snyder, 2012). Rivalry has intensified while the rate of blockbuster drug development has slowed due to an increase in regulation from the government and the industry trade association, PhRMA. The number of new entrants is fairly low and some are exiting or consolidating through mergers and acquisitions. Downstream and upstream factors are crucial to the specialty pharmaceutical sector of this industry since supply and distribution are different than in traditional branded pharmaceuticals. Complementors such as antiemetics and substitutes such as marijuana and acupuncture exist but currently do not play a large enough role to affect rivalry.…

    • 3793 Words
    • 16 Pages
    Best Essays
  • Satisfactory Essays

    Eli and Lilly

    • 462 Words
    • 2 Pages

    The country was right. Even though India was characterized by low per capita GDP, but the population of India cannot be ignored. And 200 million and 300 million of 800 million people in India were middle class. That was a huge potential market for Eli Lilly and Company. As the cost of health-care increased in developed countries in the 1990s, chose India was a good choice for a international company like Eli and Lilly. Especially could uses India as trade route to export products to Russia, so choose India had a lot of advantages.…

    • 462 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage…

    • 1400 Words
    • 6 Pages
    Powerful Essays
  • Good Essays

    Pharmaceutical industry

    • 2508 Words
    • 7 Pages

    The Pharmaceutical industry in India is the world's third-largest in terms of volume.[1] According to Department of Pharmaceuticals of the Indian Ministry of Chemicals and Fertilizers, the total turnover of India's pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion.[2] While the domestic market was worth US$12.26 billion. The industry holds a market share of $14 billion in the United States. [3]…

    • 2508 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Repositioning Ranbaxy

    • 897 Words
    • 4 Pages

    The Indian market was governed by price controls in the 1970s and 1980s – a situation that did not incentivise research. This, coupled with low per capita income resulted in demand for drugs that was not very high in sophistication. The bias for small scale resulted in over-capacity that led to excessive price competition. This kind of rivalry in the domestic market prompted Ranbaxy to adopt a differentiation strategy. Ranbaxy tried to create differentiation through Marketing and Process Technology. This resulted in improved product/brand profitability, and an increase in brand life cycle, similar to the post-patent approach adopted by many research-based companies. At about the same time, Ranbaxy embarked on an export drive. This gave Ranbaxy improved margins, an entry-point into several international markets, and an opportunity to spread its risks away from the controlled Indian market. Without doubt Ranbaxy was blessed with benign factor conditions: significant cost advantages in R&D and in manufacturing. The role of supporting industries was not very significant as import of bulk drugs, that were not produced domestically, was allowed by the Indian government…

    • 897 Words
    • 4 Pages
    Good Essays
  • Good Essays

    Ananlysis Dr. Reddy's Lab

    • 1106 Words
    • 5 Pages

    • After this extraordinary achievement of bein first Indian company to expand overseas, Dr. Reddy, formed four pillar based strategy comprising - product diversification, international expansion with branded formulation, & growth in Generic businesses. It was also well supplemented by efforts in building of capabilities in new drug discoveries to set required vision in front of the rapidly growing organization. This is considering the overall vision of Dr. Reddy himself who wanted not only acquire wealth but also quench his thrust of doing R&D in chemical sector.…

    • 1106 Words
    • 5 Pages
    Good Essays
  • Good Essays

    Pharmacy Sop

    • 1074 Words
    • 5 Pages

    The last decade has been an absolutely exciting time in the journey of the Indian Pharmaceutical Industry. With the signing of the General Agreement of Trade and Tariff and the World Trade Organization Treaty, India agreed to recognize both product and process patents. This made patented drugs with a modified process. Due to this, India has developed tremendous competitive edge in the manufacturing bulk drugs and formulations. These abundant opportunities with their challenges are where I see myself making a contribution to the Indian Pharmaceutical Industry and in turn the world at large. How and why require just brief journey into my past.…

    • 1074 Words
    • 5 Pages
    Good Essays
  • Better Essays

    In the The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and…

    • 8549 Words
    • 35 Pages
    Better Essays
  • Powerful Essays

    project report on ranbaxy

    • 9475 Words
    • 38 Pages

    The Indian pharmaceutical industry is at the center stage in the global healthcare arena and Ranbaxy endeavors to be at the forefront in delivering the India centric advantages to the advanced and developing countries of the world.…

    • 9475 Words
    • 38 Pages
    Powerful Essays
  • Satisfactory Essays

    Currently, the Canadian company has good opportunity to export their medicine to because both the countries have good economic relations. Both countries view each other as complementary economies. It could enhance their own competitiveness by integrating themselves in the global supply chain by taking advantage of India’s low-cost skilled labour. The existence of English as the common language of business should enable the Canadian company to find a suitable sales agent who would handle the marketing of its product in the foreign market (India) (Canada Service Coalition, 2007).If the Canadian company chooses exporting as their entry mode the advantages it may obtain is increased profits, reduce the risk & balance growth, Lower the unit cost and economies of scale. Another advantage…

    • 433 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Preface India is fast emerging as a favoured destination for clinical trials by global pharmaceutical and biotech companies that are looking for partnerships or setting up new operations. Two major reasons for its popularity are: easy access and availability of a large, diverse and therapy-naïve population with vast gene pool and lower cost of technical services resulting into lower per patient trial cost. India also has the advantage of having a large pool of highly trained physicians, nurses, and technical personnel; numerous world-class medical facilities; broadly developed information technology infrastructure; a favourable IPR environment (post signing the WTO agreement) and use of English as the primary business and medical language. The total value of clinical research performed in India in 2004-05 was about US$100 million. The major companies involved in Clinical research in India have a wide range of services to offer. Thus, the industry needs to know the companies operating in this field. The directory of ‘Clinical Research Companies in India’ is the answer to it…

    • 1390 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Gst India

    • 4625 Words
    • 19 Pages

    During my study I also analysed the prospects on India as a manufacturing hub for pharmaceutical industries. The possibilities and advantages of having pharmaceutical manufacturing centres in India were also explored.…

    • 4625 Words
    • 19 Pages
    Powerful Essays
  • Good Essays

    Healthcare - India M&a

    • 6226 Words
    • 25 Pages

    The last decade has seen significant consolidation in the Indian Pharmaceutical Industry driven by acquisition of large Indian generic manufacturers by top global pharmaceutical firms (such as Piramal’s and Ranbaxy’s takeover by Abbott and Daiichi Sankyo respectively). The Indian pharmaceutical industry is worth $4.5bn today and is growing at 15%+.It presents several attractive opportunities for global pharmaceutical companies. First, it gives them access to the developing world. Given the fragmented nature of the industry it is an enormous task for a company to set-up operations from scratch. An acquisition gives them customer base and distribution network. Second, it gives them cheap manufacturing facility/ labour. A third reason could be product integration – it gives the acquirers a basket of generics that they can promote in the global market. This paper also looks at the issue of patent expiration. There are a couple of companies working on the M&A format either to take over a R&D division of another company or looking at expanding their global footprint by leveraging the distribution, supplier, and intellect network of the acquired company. We will also be analyzing some instances of Indian companies acquiring foreign pharma companies. Again, the main driver of such acquisitions seems to be the desire to expand domestic generic business to international markets by leveraging the distribution networks of established companies. This paper will try to uncover some of these motivations and discuss how the companies have been faring post acquisition as also what were some of the key growth drivers…

    • 6226 Words
    • 25 Pages
    Good Essays
  • Powerful Essays

    Pharmaceutical Industry

    • 2966 Words
    • 12 Pages

    Indian Pharmaceutical Industry can be valued at around $20billion (2009). By Volume, India is world’s second largest producer of pharmaceuticals, while by value it is world’s thirteenth largest. It is expected to grow at CAGR of 12% for 2010-2012 (global average 6%).Around 95% of Domestic demand is catered by Indian Pharmaceutical companies. In Indian Pharmaceuticals Market, Formulations accounted for 65% while Bulk Drugs accounted for 35% by Value. Formulations consist of Generic as well as patented drugs though traditionally Indian Formulations industry has been strongly a Generics Industry.…

    • 2966 Words
    • 12 Pages
    Powerful Essays
  • Good Essays

    Drugs in India

    • 806 Words
    • 4 Pages

    India is a world leader in generic drug manufacturing. Their previous policies for food and pharmaceutical patents paved the way for this. Since India’s entry into the World Trade Organization (WTO) in January of 1995 there has been an increasing push for reform of India’s patent laws. While there have been reforms made to the patent laws to comply with WTO regulations, they contain vague and somewhat easily exploitable language. It is without question that affordable generics medications produced in India are necessary throughout the world especially in places like India. This essay will examine a compromise for both sides of the situation so that medications can be received by those who need them the most.…

    • 806 Words
    • 4 Pages
    Good Essays